339 related articles for article (PubMed ID: 29679493)
1. PPARs and pain.
Okine BN; Gaspar JC; Finn DP
Br J Pharmacol; 2019 May; 176(10):1421-1442. PubMed ID: 29679493
[TBL] [Abstract][Full Text] [Related]
2. Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field.
Moran MM; Szallasi A
Br J Pharmacol; 2018 Jun; 175(12):2185-2203. PubMed ID: 28924972
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel modulation as a target in chronic pain control.
Patel R; Montagut-Bordas C; Dickenson AH
Br J Pharmacol; 2018 Jun; 175(12):2173-2184. PubMed ID: 28320042
[TBL] [Abstract][Full Text] [Related]
4. Spinal α
Bahari Z; Meftahi GH
Br J Pharmacol; 2019 Jul; 176(14):2366-2381. PubMed ID: 30657594
[TBL] [Abstract][Full Text] [Related]
5. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.
Taneja A; Della Pasqua O; Danhof M
Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907
[TBL] [Abstract][Full Text] [Related]
6. Histamine, histamine receptors, and neuropathic pain relief.
Obara I; Telezhkin V; Alrashdi I; Chazot PL
Br J Pharmacol; 2020 Feb; 177(3):580-599. PubMed ID: 31046146
[TBL] [Abstract][Full Text] [Related]
7. α9-containing nicotinic acetylcholine receptors and the modulation of pain.
Hone AJ; Servent D; McIntosh JM
Br J Pharmacol; 2018 Jun; 175(11):1915-1927. PubMed ID: 28662295
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in targeting ion channels to treat chronic pain.
Stevens EB; Stephens GJ
Br J Pharmacol; 2018 Jun; 175(12):2133-2137. PubMed ID: 29878335
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of bisphosphonates in pain.
Tzschentke TM
Br J Pharmacol; 2021 May; 178(9):1973-1994. PubMed ID: 31347149
[TBL] [Abstract][Full Text] [Related]
10. P2X receptor channels in chronic pain pathways.
Bernier LP; Ase AR; Séguéla P
Br J Pharmacol; 2018 Jun; 175(12):2219-2230. PubMed ID: 28728214
[TBL] [Abstract][Full Text] [Related]
11. Is TRPA1
Giorgi S; Nikolaeva-Koleva M; Alarcón-Alarcón D; Butrón L; González-Rodríguez S
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197115
[TBL] [Abstract][Full Text] [Related]
12. An overview on biological mechanisms of PPARs.
Kota BP; Huang TH; Roufogalis BD
Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
Gaborit M; Massotte D
Br J Pharmacol; 2023 Apr; 180(7):994-1013. PubMed ID: 34883528
[TBL] [Abstract][Full Text] [Related]
14. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
Menendez-Gutierrez MP; Roszer T; Ricote M
Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
[TBL] [Abstract][Full Text] [Related]
15. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures.
Parenti C; Turnaturi R; Aricò G; Gramowski-Voss A; Schroeder OH; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
Neuropharmacology; 2013 Aug; 71():70-82. PubMed ID: 23541722
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and their actions: An update.
Alexander SPH; Molina-Holgado F
Br J Pharmacol; 2019 May; 176(10):1359-1360. PubMed ID: 31032895
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
18. Injury-induced maladaptation and dysregulation of calcium channel α
Gong N; Park J; Luo ZD
Br J Pharmacol; 2018 Jun; 175(12):2231-2243. PubMed ID: 28646556
[TBL] [Abstract][Full Text] [Related]
19. Progress of clinical practice on the management of burn-associated pain: Lessons from animal models.
McIntyre MK; Clifford JL; Maani CV; Burmeister DM
Burns; 2016 Sep; 42(6):1161-72. PubMed ID: 26906668
[TBL] [Abstract][Full Text] [Related]
20. PPARs at the crossroads of lipid signaling and inflammation.
Wahli W; Michalik L
Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
